Pregled bibliografske jedinice broj: 1058481
Side effects of a dopamine agonist therapy for Parkinson’s disease: a mini-review of clinical pharmacology
Side effects of a dopamine agonist therapy for Parkinson’s disease: a mini-review of clinical pharmacology // Yale journal of biology and medicine, 89 (2016), 1; 37-47 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1058481 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Side effects of a dopamine agonist therapy for
Parkinson’s disease: a mini-review of clinical
pharmacology
Autori
Borovac, Josip Anđelo
Izvornik
Yale journal of biology and medicine (0044-0086) 89
(2016), 1;
37-47
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
Parkinson’s disease ; adverse effects ; clinical ; dopamine ; dopamine agonists ; patient safety ; pharmacology ; side effects
Sažetak
Dopamine agonists (DA) are therapeutic agents that are commonly used in the treatment of Parkinson's disease (PD). They can reduce undesired motor fluctuations and delay the administration of levodopa therapy. However, this drug family is associated with specific side effects that can significantly diminish the quality of life among PD patients. Some of them impose significant risks for individuals who have a history of cardiovascular diseases, psychosis, and depression, or those older patients who suffer from renal or hepatic insufficiency. Various pharmacokinetic and pharmacodynamic considerations need to be taken into account when administering DA therapy. The goal of this review is to provide a comprehensive, up-to-date overview of DA therapeutic modalities for PD.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Split,
Sveučilište u Splitu
Profili:
Josip Anđelo Borovac
(autor)
Poveznice na cjeloviti tekst rada:
Pristup cjelovitom tekstu rada www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.govCitiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE